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Abstract
Cells have evolved mechanisms to sense the composition of their adhesive microenvironment. Although
much is known about general mechanisms employed by adhesion receptors to relay signals between the
extracellular environment and the cytoskeleton, the nuances of ligand-specific signalling remain undefined.
Here, we investigated how glomerular podocytes, and four other basement membrane-associated cell types,
respond morphologically to different basement membrane ligands. We defined the composition of the
respective adhesion complexes using mass spectrometry-based proteomics. On type IV collagen, all
epithelial cell types adopted a round morphology, with a single lamellipodium and large adhesion complexes
rich in actin-binding proteins. On laminin (511 or 521), all cell types attached to a similar degree but were
polygonal in shape with small adhesion complexes enriched in endocytic and microtubule-binding proteins.
Consistent with their distinctive morphologies, cells on type IV collagen exhibited high Rac1 activity, while
those on laminin had elevated PKCa. Perturbation of PKCa was able to interchange morphology consistent
with a key role for this pathway in matrix ligand-specific signalling. Therefore, this study defines the switchable
basement membrane adhesome and highlights two key signalling pathways within the systems that determine
distinct cell morphologies. Proteomic data are available via ProteomeXchange with identifier PXD017913.
© 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
1. Introduction
Adhesion to extracellular matrices has a profound
effect on cell morphology, proliferation and migra-
tion. Since interstitial matrices, basement mem-
branes (BMs) and other extracellular assemblies
support specialized functions, it follows that cells
have evolved mechanisms to sense the composition
of their adhesive microenvironment. However, while
much is now known about the general mechanisms
employed by adhesion receptors to relay signals
between the extracellular environment and the
cytoskeleton, ligand-specific signalling is not fully
understood.
0022-2836/© 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/). Matrix Biology. (2020) 90, 61e78
Fig. 1. Adhesion to basement membrane ligand determines cellular morphology. (A) Podocytes were allowed to attach
to plates coated with 0e10 mg/ml of matrix substrate for 30 min in serum-free media. Non-attached cells were removed by
washing with PBS, and the percent of added cells attached to the substrate was quantified by crystal violet staining. (B)
Podocytes attached to 5 mg/ml of matrix substrate for 240 min in serum-free media; collagen IV, laminin 511 and laminin
521. Cell spread area was calculated using phase-contrast live cell imaging. Measurements of cell area were extracted
using Fiji ImageJ. (CeJ) Podocytes were spread on 5 mg/ml of matrix substrate for 210 min in serum-free media. (C)
Phalloidin staining of podocytes highlights distinct cellular shapes and actin structures within podocytes adhered to
collagen IV compared with laminin. The colour-coded shape outlines indicate representative protrusive activities at 5-min
intervals recorded between 180 and 280 min of cell spreading. (D) Podocytes circularity assessment when attached to
collagen IV compared with laminin. Circularity was calculated using Fiji ImageJ. (E) Cell morphology was assessed using
Fiji ImageJ; cells were manually categorised as rounded elongated or containing multiple protrusions. Podocytes had
more elongated shapes and also produced more pseudopodial protrusions when spread on laminin compared with
collagen IV. (F) Integrin b1 foci were larger in podocytes spread on collagen IV compared with podocytes spread on
laminin. (GeH) Ratio imaging demonstrated differential localization of (G) vinculin and (H) talin to integrin adhesion
complexes formed on collagen IV and laminin. (IeJ) Immunofluorescence of Integrin b1 and (I) vinculin and (J) talin in
podocytes spread on collagen IV or laminin. For attachment and spreading assays, experiments were performed four
times. For immunofluorescence and morphology-determining experiments, 20e40 cells were measured per experiment
and each experiment was performed four times. (I, J) Scale bar represents 10 mm; ****, p < 0.0001; NS, not significant;
LAM511, laminin-511; LAM521, laminin-521; COL4, collagen IV. Bar and line graph measurements are shown as mean ±
standard deviation. Box plots indicate 25th and 75th percentiles (lower and upper bounds, respectively), 1.5 interquartile
range (whiskers) and median (black line). (For interpretation of the references to colour in this figure legend, the reader is
referred to the Web version of this article.)
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Type IV collagen and laminin isoforms are core
BM components and due to associations with human
disease, they have been extensively investigated in
the kidney glomerulus. This structure consists of
specialized capillaries lined by glomerular endothe-
lial cells and covered by epithelial podocytes. These
two cell types engage the intervening glomerular BM
and together this specialized capillary wall forms the
kidney filtration barrier. During development, the
glomerular BM is rich in laminin a5b1g1 (laminin
511) and type IV collagen a1a1a2, whereas laminin
a5b2g1 (laminin 521) and type IV collagen a3a4a5
isoforms predominate in the mature glomerulus [1,2].
Podocytes adhere to the BM via integrins,
leading to the recruitment of a diverse range of
adaptor and signalling molecules to integrin cyto-
plasmic tails. These integrin adhesion complexes
(IACs) tether the podocyte cytoskeleton to the
underlying matrix and provide a mechanism for
podocytes to sense and interpret the integrity of the
BM. Several analytical approaches have been used
to elucidate the proteins that comprise IACs when
cells adhere to fibronectin-rich matrix substrates. At
least 232 proteins have been robustly identified
using targeted, candidate-based approaches [3,4]
and many more using global mass spectrometry
(MS)-based proteomic approaches [5e8]. Using
MS, IACs have been characterized at the level of
activation[9], phosphorylation [10], and integrin
receptor isoform specificity [6,11]. Recent integra-
tion of global proteomic datasets has enabled the
definition of a consensus adhesome of core
adhesion machinery comprising 60 components
[12]. However, these studies have not included BM
ligands; therefore, we aimed to investigate the
influence of BM ligand on IAC composition and the
associated consequences for cellular signalling and
morphology.
Interpretation of matrix substrate is critical for
cells. Both matrix and integrins are differentially
expressed throughout human tissues, and specific
matrix-integrin interactions are important for the
function of distinct tissues [13]. Furthermore, muta-
tions in adhesion signalling and BM components
have a profound impact on cell function [14,15].
One example is Pierson syndrome, a rare form of
congenital kidney disease: these patients have
severe proteinuria and podocyte abnormalities
caused by mutations in LAMB2 [16]. A second
example is Alport syndrome, caused by COL4A3,
COL4A4 or COL4A5 mutations in humans, which
leads to progressive loss of kidney function asso-
ciated with sensory neuronal hearing loss [17e19].
Recent studies have shown that podocytes usually
adhere to laminin in the normal glomerular BM,
whereas in Alport syndrome podocytes make
contact with ectopic type IV collagen a1a1a2,
potentially disrupting normal podocyte adhesion
signalling [20]. We therefore selected the podocyte
as a BM ligand-responsive cell type to study
differences in IAC composition on distinct BM
ligands.
We analysed podocyte responses to type IV
collagen and laminin (511 and 521) and we
observed distinct cell shapes and signalling. Further-
more, we confirmed the same ligand-dependent
changes in morphology in four other BM-associated
cell types. We proceeded to analyze IACs using MS-
based proteomics and identified BM ligand-depen-
dent adhesion complexes characterized by the
pivotal components Rac1 and PKCa, which could
be manipulated to effect BM ligand-dependent
morphologies.
Results
Basement membrane ligand determines cell
shape
To study cell shape responses to BM ligands,
human podocytes were allowed to attach and spread
on type IV collagen a1a1a2 (collagen IV), laminin
511 (which predominates during glomerular devel-
opment) or laminin 521 (the main isoform in the
mature BM). Cells attached to all three ligands at low
concentrations (Fig. 1A), but spreading occurred
more rapidly on collagen IV (Fig. 1B). On all three
substrates, however, podocytes reached the same
average spread cell area within 210 min (Fig. 1B).
The laminin receptor a3b1 integrin and the tightly-
associated tetraspanin CD151 were highly
expressed on the podocyte cell surface as deter-
mined by flow cytometry (Supplementary Fig. 1A). In
addition, we observed differential levels of expres-
sion of phosphorylated paxillin (Y118) compared to
b1 integrin on collagen IV and laminin, suggesting
distinct integrin adhesion complexes (Supplemen-
tary Fig. 1B).
Irrespective of the degree of spreading, collagen
IV and laminin induced different cell shapes. On type
IV collagen, podocytes spread, but adopted a
circular shape and were rarely polarized. The cells
exhibited radial actin stress fibres and a single
lamellipodium that often encompassed the entire cell
edge (Fig. 1CeE). These cells also formed large b1
integrin-, vinculin- and talin-positive integrin adhe-
sion complexes (IACs; Fig. 1FeJ). In contrast,
podocytes spread on laminin 511 or 521 were
elongated and polygonal with a large number of
pseudopodial projections (Fig. 1CeE) and smaller
IACs (Fig. 1FeJ). Under all conditions, there was no
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Fig. 2. Signalling response to basement membrane (BM) ligands. (AeD) Canonical integrin signalling assayed by
Western blot of total cell lysates from podocytes spreading on BM ligands over a 210-min time course of cells spread on
5 mg/ml of matrix substrate. (AeD) Podocyte P-Erk (T202/Y204), P-Akt (S473), P-Src (T416) and P-FAK (Y397) levels at 0,
15, 30 and 210 min of cell spreading onto either type IV collagen or laminin 511. Band intensity was calculated using
integrated density in Fiji imageJ. (E) Immunofluorescence and ratio imaging quantification of P-FAK (Y397) and Integrin b1
in podocytes after 210 min of cell spreading onto BM ligands. For these experiments 20 cells were measured per
experiment and each experiment was performed four times (F) GST-PAK pull down of active Rac1 assayed in podocytes
spreading in serum-free media on 5 mg/ml of matrix substrate over a 210-min time course (0, 15, 30, 105 and 210min of cell
spreading). All bar graph measurements are shown as mean ± standard deviation. Box plots indicate 25th and 75th
percentiles (lower and upper bounds, respectively), 1.5 interquartile range (whiskers) and median (black line). Scale bar
in (E) represents 10 mm; ****, p < 0.0001; NS, not significant; LAM511, laminin-511; COL4, collagen IV.
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significant difference in cell responses to the two
different laminin isoforms, consistent with both
heterotrimers sharing the same integrin-binding
domain in the a5 chain [21e25]. For this reason,
the majority of subsequent experiments compared
collagen IV with laminin 511.
We also examined cell shape on fibronectin as this
matrix ligand localizes to BMs in certain circum-
stances and it is also abundant in cell culture.
Podocytes on fibronectin reached a similar spread
area to cells on laminin (Supplementary Fig. 1C and
D) but they were more rounded. Furthermore, we
compared cell area with the addition RGD peptide at
a concentration to inhibit fibronectin engagement
with a5b1 or avb3 integrins. Cell spreading on
fibronectin was reduced significantly, whilst the
area of podocytes on collagen IV and laminin was
preserved following RGD peptide treatment (Sup-
plementary Fig. 1C and D). This indicates that the
BM ligands laminin and collagen IV were dominant in
the experimental system we used.
To test the generality of the morphological
response to collagen IV and laminin, a retinal
pigment epithelial cell line (ARPE19), glomerular
endothelial cells (GEnCs) and HEK293T cells were
examined. In vivo, retinal pigment epithelial cells
contact Bruch's membrane, which has a similar
composition to the glomerular BM [26e28]. All three
cell types showed morphological dependence on
ligand, with laminin inducing polarization and protru-
sion, and type IV collagen leading cells to adopt
circular morphologies (Supplementary Fig. 2 A-F).
We further assessed the impact of adhesion to
collagen IV or laminin on cellular phenotype using a
dorsal root ganglion (DRG) neurite outgrowth assay.
Podocytes express a number of neuronal markers,
and podocyte branching and foot process formation
are thought to employ similar guidance cues to that
of neurite outgrowth [29e31]. DRG outgrowth
occurred on both collagen IV and laminin, but the
average length of neurites on laminin was signifi-
cantly greater than those generated on type IV
collagen (Supplementary Fig. 2G and H), again
demonstrating BM influence on cellular phenotype.
Thus, for a range of cell types, adhesion to
collagen IV induces a rounded phenotype, while
Fig. 3. Focal adhesion signalling on micropatterned surfaces. (A) Micropatterned circles and lines with an area of
2800 mm2 were prepared and coated with collagen IV or laminin 511 (both at 5 mg/ml). Podocytes were spread on the
micropatterned surfaces for 3.5 h in serum-free media. Podocytes adapted the round and elongated cell shapes on both
ligands and formed paxillin-positive adhesions. Scale bar represents 10 mm. (B) Cells were stained for Paxillin and
phospho-paxillin (Y118). Scale bar represents 2 mm. (C) Ratiometric imaging was performed on adhesions, quantifying
phosphorylated paxillin (Y118) levels relative to paxillin levels. Data are pooled from three independent experiments;
40e60 cells were analysed per condition; ****, p < 0.0001; **, p < 0.01.
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laminin 511 supports a protrusive phenotype.
Although b1 integrins mediate adhesion to both
ligands, these findings imply both compositional
differences in the associated IACs and differences in
signal transduction to the cytoskeleton.
Matrix ligand and cell morphology influence
cellular signalling
To gain a greater understanding of the link
between cell morphology, protrusive activity and
BM ligand, we assessed canonical integrin signal-
ling. AKT and ERK1/2 were activated in podocytes
during cell spreading on collagen IV and laminin
ligands to the same degree (Fig. 2AeB). In contrast,
Src and FAK activation were both enhanced on
collagen IV compared with laminin (Fig. 2CeD).
These differences were also observed with immuno-
fluorescence microscopy, where the amount of
phosphorylated FAK (Y397) localized to IACs was
increased on collagen IV compared with laminin
(Fig. 2E). The phosphorylated form of another
canonical integrin signalling protein, paxillin Y118,
was also enriched in collagen IV IACs compared
with laminin IACs (Supplementary Fig. 1B). Since
podocytes spread on collagen IV had an appearance
consistent with hyperactivated Rac1, we quantified
Rac1 activity using PAK1 pulldown. Rac1 activity
was significantly increased in podocytes spread on
collagen IV compared with laminin (Fig. 2F).
Once a cell engages with a BM ligand, its shape is
altered, and our data in Figs. 1 and 2 demonstrate
that there is differential signalling on BM ligands. To
determine whether the BM ligand or the resulting cell
morphology had the predominant influence on focal
adhesion signalling, we spread podocytes on micro-
patterned circles or lines and examined phosphory-
lated paxillin (Y118) specifically at focal adhesions
(Fig. 3A). Podocytes on collagen IV circles had the
highest phospho-paxillin to paxillin ratio, whereas
podocytes on laminin lines had the lowest ratio and
there was a gradient between (Fig. 3BeC and
Supplementary Fig. 2I). This suggests that, even
when a particular shape is enforced, the BM ligand
has a dominant effect on focal adhesion signalling.
The composition of the adhesome is matrix
ligand-dependent
To investigate how adhesion to collagen IV or
laminin influences adhesion signalling and cell
shape, we isolated basolateral IAC using estab-
lished methods [32] from podocytes spread onto BM
substrates. Podocytes were allowed to attach to
collagen IV, laminin-511 or laminin-521 and form
IACs. Subsequently, IACs were stabilized using a
reversible crosslinker and podocyte cell bodies and
nuclei removed by detergent lysis and hydrodynamic
force (Supplementary Fig. 3A). The purity of the
matrix ligands was assessed by MS. Collagen IV,
laminin 511 and laminin 521 all demonstrated a high
degree of purity (Supplementary Fig. 3B).
IAC marker proteins talin and vinculin were
detected in isolated IACs, but proteins that do not
localize to IACs, such as Bcl-2 homologous antago-
nist/killer (BAK) and heat shock 70 kDa protein
(HSP70), were not found (Supplementary Fig. 3D
and E). Apotransferrin was used as a negative
control for proteins that are basolateral but not IAC-
associated. Cells attached to apotransferrin, but did
not spread and remained phase bright (Supplemen-
tary Fig. 3F). Talin and vinculin were not detected in
these complexes by western blotting (Supplemen-
tary Fig. 3D), while MS analysis revealed a high
Fig. 4. The adhesome is matrix ligand dependent. (A) Principal component analysis of mass spectrometry data from
podocytes. Circles represent biological replicates. (B) Unsupervised hierarchical clustering analysis of integrin adhesion
complexes (IACs). Clustering was performed on the basis of Euclidian distance. The heat map displays row z-score,
plotted in hotecold colour scale, with hot (red-orange) indicating high abundance and cold (green-blue) indicating low
abundance. Summary protein profiles across conditions are displayed. Grey lines show individual protein profiles in the
highlighted cluster and the central coloured line represents the mean protein abundance of the cluster. Associated Gene
Ontology enrichment maps demonstrate enriched biological processes. The size of the nodes (circles) represents the
number of proteins, the grey lines (edges) between the nodes represents overlap of proteins within biological process
terms. The intensity (opacity) of colouring represents the p value of the enrichment. (C) Protein-protein interaction network
constructed from known integrin adhesion components that were identified by mass spectrometry. Proteins are sorted into
different categories. Edges represent protein-protein interactions, nodes represent proteins. Solid edges represent
reported protein-protein interactions detected using multiple different techniques, dashed lines represent lower confidence
interactions detected with single techniques. Coloured nodes represent those with significantly different abundance in
laminin (511 and 521 combined) IACs compared with collagen IV IACs. (D) Immunofluorescence of filamin A and integrin
b1 in cells spread on matrix-ligand for 210 min. (E) Immunofluorescence of PKCa and integrin b1 in cells spread on matrix-
ligand for 210min. (FeJ) Ratio imaging analysis of integrin adhesion components identified as either laminin or collagen IV
enriched by MS. For immunofluorescence and morphology-determining experiments, 20e40 cells were measured per
experiment and each experiment was performed four times. Box plots indicate 25th and 75th percentiles (lower and upper
bounds, respectively), 1.5  interquartile range (whiskers) and median (black line). Scale bar in (D, E) represents 10 mm;
****, p < 0.0001; NS, not significant; LAM511, laminin-511; COL4, collagen IV; ApoT, apotransferrin. (For interpretation of
the references to colour in this figure legend, the reader is referred to the Web version of this article.)
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abundance of the transferrin receptor and low
abundance of integrin receptors in apotransferrin
complexes (Supplementary Fig. 3C). In contrast,
integrins were enriched in IACs and included the b1,
a1, a2, a3, a5 and aV subunits. These data suggest
that podocytes utilise aVb1 to a similar degree when
spreading on BM ligands and this may reflect the
presence of fibronectin in cell culture. In contrast,
integrin a3b1 is utilized to a greater degree by
podocytes when spreading on laminin, whereas
podocytes enlist a combination of a1b1, a2b1 and
a5b1 to a greater degree when spreading on type IV
collagen (Supplementary Fig. 3C, Supplementary
Table 1).
Principal component analysis and hierarchical
clustering highlighted the relationship between
replicates, with collagen IV IACs and laminin IACs
grouping separately, suggesting heterodimer-speci-
fic components are present in laminin and collagen
IV IACs (Fig. 4AeB). In keeping with previous
experiments, laminin 511 and laminin 521 IACs
were largely indistinguishable, with only the laminin
b1 and b2 changed in abundance between the two
conditions (Fig. 4AeB, Supplementary Table 1).
Gene Ontology enrichment analysis revealed that
actin-binding proteins were enriched in collagen IV
IACs, whereas microtubule-binding proteins and
endocytic machinery components were enriched in
laminin IACs (Fig. 4B).
The basement membrane adhesome comprises
consensus adhesome components
MS analysis of IACs was also performed in
ARPE19 cells. In general, there was congruence
between the two datasets (Supplementary Fig. 4A,
Supplementary Table 2). In terms of both number
and abundance of proteins, the type IV collagen
adhesome resembled more closely the known
fibronectin consensus adhesome, with most of the
less well connected and characterized consensus
components enriched in laminin IACs (Supplemen-
tary Fig. 4C, Supplementary Tables 3 and 4). In
order to focus on known IAC components, we
generated protein-protein interaction networks
using the consensus adhesome (Supplementary
Fig. 4C) and literature-curated adhesome (Fig. 4C).
Interestingly, we identified a number of Rac1-
interacting proteins that were differentially recruited
to IACs dependent on BM ligand (Supplementary
Fig. 3D). Filamin A and IQGAP1, which interact to
suppress Rac1 activity, were enriched in collagen IV
IACs [33]. In contrast, RCC2, also known to
suppress Rac1 activity [8], was enriched in laminin
IACs. These data suggest that, dependent on the
adhesion type, different pathways are utilized by
cells to curtail Rac1 activity.
We validated the findings from MS using immuno-
fluorescence (Fig. 4DeJ, Supplementary Fig. 5A). In
the MS dataset, filamin A and Hic5 were enriched in
collagen IV IACs, whereas caveolin-1 and ezrin,
radixin, moesin (ERM) proteins were enriched in
laminin IACs: the patterns of enrichment were
confirmed by fluorescence imaging and ratio ima-
ging quantification (Fig. 4DeJ, Supplementary
Fig. 5A). Furthermore, myosin-1E localized to IACs
and was more abundant in laminin IACs than
collagen IV IACs (Supplementary Table 5, Supple-
mentary Fig. 5B). Myosin-1E is of particular interest
as mutations in MYO1E cause nephrotic syndrome
[34] and it has also been implicated as a genetic
modifier in Alport syndrome [35]. We also identified
ARHGAP29 in podocyte IACs and validated this by
immunofluorescence (Supplementary Fig. 5C). Both
ARHGAP29 and myosin-1E localized to circular
adhesions that form underneath the nucleus (Sup-
plementary Fig. 5B and C). EPB41L3 was also
detected in podocyte IACs and was equally abun-
dant in both collagen IV and laminin IACs (Supple-
mentary Table 5).
PKCa adhesion signalling is matrix ligand-
dependent
Although consensus adhesome proteins were
enriched in IACs formed on collagen IV, many
kinases and phosphatases were enriched in laminin
IACs (Supplementary Table 4). Protein kinase C
Fig. 5. Modulating PKC alters cell morphology and signalling. (A) Western blot demonstrates PKC activity in both total
cell lysates and integrin adhesion complexes from podocytes spread onto collagen IV or laminin for 210 min. (B) The
colour-coded shape outlines indicate representative protrusive activities at 5-min intervals recorded over 100-min period.
For measurements of protrusive activity live cell imaging was performed between 180 and 280 min of cell spreading.
Podocytes were treated with either GӦ6976 or PMA to suppress or induce PKC activity respectively during cell spreading
on matrix ligand. (C,D) PKCmodulation impacts podocyte morphology and pseudopodial projection formation. (E,F) PKCa
localization to adhesions is controlled through ligand specificity. Podocytes were spread on circles and lines coated with
collagen IV or laminin for 3.5 h in serum-free media and stained for PKCa and paxillin and ratiometric imaging was
performed. Scale bar represents 20 mm. Data are pooled from three independent experiments. GӦ6976 induced inhibition
of PKCa localization to FA was significant for collagen circles, lines and laminin lines. For ratiometric imaging 20e40 cells
were analysed per experiment and each experiment was performed four times. All bar graph measurements are shown as
mean ± standard deviation. Box plots indicate 25th and 75th percentiles (lower and upper bounds, respectively),
1.5  interquartile range (whiskers) and median (black line). Scale bar in (e) represents 5 mm; ****, p < 0.0001; NS, not
significant; LAM511, laminin-511; COL4, collagen IV. (For interpretation of the references to colour in this figure legend,
the reader is referred to the Web version of this article.)
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alpha (PKCa) was highly enriched in laminin IACs
(Fig. 4C, E, H). We therefore investigated the role of
PKCa during adhesion to BM ligands. PKC activity in
total cell lysates from cells adhered to collagen IV or
laminin was similar, whereas PKC activity was
enhanced in isolated laminin IACs compared with
collagen IV IACs (Fig. 5A). The role of PKCa in
influencing cellular morphology was tested by alter-
ing PKC signalling using phorbol 12-myristate 13-
acetate (PMA) as an activator of PKC or GӦ6976 as
an inhibitor. Inhibition of PKC induced cells on
laminin to becomemodestly rounded, phenotypically
similar to those spreading on collagen IV, whereas
activating PKC in cells spreading on collagen IV
induced the cells to produce more pseudopodial
projections and resemble cells spreading on laminin
(Fig. 5BeD). To examine the role of cell shape in
directing ligand-mediated signalling, PKCa levels
Fig. 6. Integrin a3 and PKC are involved in matrix interpretation. (A) Deletion of ITGA3 from HEK293T cells using two
different CRISPR-Cas9 guide RNAs. Ctrl, scrambled guide RNA. Lane 1, molecular weight marker; lane 2, control guide RNA;
lane 3, ITGA3 guide RNA 1 targeted cells prior to fluorescent activated cell sorting; lane 4, ITGA3 guide RNA 2 targeted cells
prior to fluorescent activated cell sorting; lane 5, ITGA3 guide RNA 1 targeted cells after fluorescent activated cell sorting; lane
6, ITGA3 guide RNA 1 targeted cells after fluorescent activated cell sorting. (B) Immunofluorescence of ITGA3-KO cells
spread onto matrix ligand for 210 min. (C) Western blot demonstrates PKC activity in integrin adhesion complexes from
ITGA3-KO cells spread onto matrix ligand for 210 min. (DeF) Deletion of ITGA3 impacts cell morphology and pseudopodial
projection formation. (G) GST-PAK pull down of active Rac1 assayed in podocytes spreading on BM ligands over a 210-min
time course. All bar graph measurements are shown as mean ± standard deviation. For immunofluorescence and
morphology-determining experiments, 20e40 cells were measured per experiment and each experiment was performed four
times. All bar graph measurements are shown as mean ± standard deviation. Box plots indicate 25th and 75th percentiles
(lower and upper bounds, respectively), 1.5  interquartile range (whiskers) and median (black line). Scale bar in (f)
represents 10 mm; ****, p < 0.0001; NS, not significant; LAM511, laminin-511; COL4, collagen IV.
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were investigated in the adhesions of cells spread on
collagen IV and laminin micropatterns. In line with
our previous findings, highest PKCa levels were
observed at adhesions on laminin lines and less
PKCa localization to adhesions on collagen circles.
Spreading podocytes on laminin circles decreased
localization of PKCa to adhesions, suggesting a
potential contribution of the cell morphology towards
cellular signalling, which was abolished upon
GӦ6976-induced inhibition of PKCa (Fig. 5E and
F). Furthermore, treatment with PKCa modulators
had effects on both the actin and microtubule
cytoskeleton during cell adhesion (Supplementary
Fig. 6A). The role of PKC signalling in matrix
interpretation was also tested in DRG neurite
outgrowth assays. Inhibition of PKC using GӦ6976
reduced neurite length in cells on laminin, but had no
effect on collagen IV (Supplementary Fig. 6B).
Conversely, PMA enhanced neurite length on
collagen IV at 8 h, but this was not seen with laminin
(Supplementary Fig. 6B).
Integrin a3 and PKCa cooperate in laminin
matrix interpretation
As the integrin a3 subunit was the only integrin
receptor that we identified enriched in laminin IACs
(Fig. 4C, Supplementary Fig. 3C and Supplementary
Table 1), we explored the relationship between
integrin a3, PKCa and cell morphology. Using
CRISPR-Cas9, ITGA3-null (ITGA3-KO) cells were
generated (Fig. 6A) and spreading assays on
collagen IV or laminin were performed. ITGA3-KO
cells still attached to laminin, but had reduced
spreading, formed fewer pseudopodial projections
and had reduced PKCa signalling in isolated IACs
(Fig. 6BeF). When ITGA3-KO cells adhered to
collagen IV, the cells had increased cell area and
there was also an effect on PKCa signalling at IACs
(Fig. 6BeF). Interestingly, the ITGA3-KO cells plated
onto collagen IV displayed an opposing phenotype
to cells plated onto laminin, with increased cell
spread area, PKCa signalling and decreased circu-
larity, and this could indicate utilization of alternative
integrin heterodimers. Finally, Rac1 activity in
podocytes during spreading on collagen IV was not
significantly influenced by either PKC activation or
inhibition. In contrast, during cell spreading on
laminin, podocyte Rac1 activity was modestly
increased by PKC inhibition but not influenced by
PKC activation. This suggests alternative mechan-
isms of Rac1 inhibition dependent on IAC composi-
tion (Fig. 6G). Overall, these findings suggest that an
integrin a3 to laminin interaction influences PKC
signalling, and this pathway promotes pseudopodial
generation and an elongated cell shape.
Discussion
In this investigation, we have defined the adhe-
some of cells engaging with basement membrane
ligands. We discovered that: 1) laminin-based
adhesion signalling led to elongated cells with
multiple extended pseudopodial projections, remi-
niscent of foot process structures formed by podo-
cytes in vivo; 2) type IV collagen-based adhesion
induced circular cell phenotypes associated with
hyperactivated Rac1; and 3) these differential
responses to BM ligand were not unique to
podocytes but also identified in retinal pigment
epithelial cells, glomerular endothelial cells,
HEK293T and neurites. Although previous studies
have described laminin and collagen ligands indu-
cing different cell morphologies [36], this study is the
first to substantiate these observations with detailed
MS-based investigation of IACs and the definition of
key cell signalling components responsible for
determining cell shape (PKCa and Rac1).
BMs underlie all sheets of cells and are composed
of condensed networks of matrix proteins. Core BM
constituents include type IV collagen, laminin iso-
forms, nidogens and heparan sulfate proteoglycans;
however, MS-based proteomic studies have
revealed the complex nature of BMs and have
identified tissue-specific expression of hundreds of
BM components [37]. Tissue-specific expression is
likely to represent the variable functional roles of
BMs from a semi-permeable membrane (in the
kidney filter, blood-brain barrier and the blood-retinal
barrier) to an impermeable structural scaffold (in the
skin or intestine). Cells adhere to BMs via IACs yet it
is unclear which BM ligand cells preferentially
engage. The nanoscale architecture of the glomer-
ular BM was investigated using correlative STORM-
EM imaging [20] and these data suggest that, in
health, podocytes and endothelial cells engage
laminin rather than type IV collagen and this
engagement is switched in kidney diseases such
as Alport syndrome [20]. This study also localized
type IV collagen to the middle of the healthy
glomerular BM, perhaps indicating a stabilising role
upon fusion of the endothelial and podocyte BMs
during development [38].
In this study, we observed striking differences in
the morphologies of cells on laminin and type IV
collagen. These morphological patterns were
observed in several cell types that engage BM
ligands (glomerular podocytes and endothelial cells,
HEK293 cells, retinal pigment epithelial cells and
neuronal cells), suggesting that the interpretation of
BM ligand is conserved between cell types. The
morphological patterns we observed may also relate
to pathological changes in vivo. In the kidney,
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healthy podocytes have large cell bodies with
multiple cellular extensions or foot processes that
cover the surfaces of the glomerular capillaries and
interdigitate with processes from neighbouring cells.
In this situation, podocytes engage laminin at the
cell-matrix interface [20]; however, in glomerular
disease, podocytes undergo a considerable change
in morphology and become effaced and flattened.
Although this morphological switch has been recog-
nized for decades, the associated changes in
signalling are not well understood. In the effaced
state, podocytes may be exposed to alternative
matrix ligands, including ectopic type IV collagen,
and this ligand switch could drive outside-in signal-
ling to effect altered morphology.
To gain insight into the signalling pathways
involved in the morphological switch, we used MS-
based proteomics and demonstrated that podocyte
IAC composition is dependent on BM ligand. Actin-
binding machinery was enriched in collagen IV IACs,
whereas microtubule-binding and endocytic machin-
ery were enriched in laminin adhesion complexes.
This is in keeping with studies that have shown the
importance of laminin to integrin b1 interactions
promoting microtubule assembly and stabilization in
axons [39]. This observation suggests that collagen
IV adhesion complexes form more robust links to the
actin cytoskeleton thereby generating more tension
and enhanced Rho family GTPase activity. In
contrast, MS data suggest that laminin adhesion
complexes may be hubs for kinase signalling and
microtubule regulation, and that they may also be
more readily turned over. Focusing on specific
candidates from the MS analysis, we validated
myosin-1E and ARHGAP29 as novel IAC compo-
nents, which also localized to atypical adhesion
structures. We also identified PKCa enrichment in
laminin IACs and further study suggested integrin a3
and PKCa signalling downstream of laminin is an
important determinant of cell morphology in cells
attached to laminin. Accordingly, upon integrin a3
knockout, cells spreading on laminin showed
decreased PKCa activation and acquired a round
shape. In contrast, the knocked-down cells plated on
collagen IV displayed an opposite phenotype, with
increased PKCa activation; higher cell spread area
and reduced cell circularity. We speculate that this
opposing phenotype could be linked to increased
available b1 integrin forming alternative heterodi-
mers in the absence of a3. We further speculate that
cells spreading on collagen are able to utilise these
alternative heterodimers more effectively than cells
spreading on laminin.
In conclusion, we have defined the composition of
IACs in cells engaging BM ligands and have
identified key signalling pathways acting through
these protein complexes to effect changes in cell
shape. Further investigation of how differential
integrin-ligand binding triggers different signalling
pathways could lead to strategies to switch cell
morphology, which may have therapeutic implica-
tions for a range of human diseases.
Experimental procedures
Antibodies
Antibodies used were against mouse anti-human
paxillin (clone 349; BD Biosciences), mouse anti-
human CD151 (11G5a; Abcam), rat anti-human
integrin a6 (GoH3; Abcam), rat anti-human integrin
b1 (9EG7), mouse anti-human caveolin 1 (clone
2297; BD Biosciences), mouse anti-human integrin
a1 (FB12; Millipore), mouse anti-human ezrin/
radixin/moesin (EMD Millipore), mouse anti-human
integrin a2 (P1E6; Abcam), mouse anti-human
integrin a3 (IA3 clone; ab20141; Abcam) (P1B5;
ab24696; Abcam), goat anti-human integrin a3 (I-19
Santa Cruz Biotechnology), mouse anti-human
Rac1 (BD Biosciences), mouse anti-human integrin
a4 (HP2/1; Abcam), mouse anti-human integrin
avb3 (LM609; Millipore), mouse polyclonal vinculin
(hVin1; Sigma-Aldrich), polyclonal rabbit anti-human
p (Y397)FAK (44-624G; Invitrogen), rabbit anti-
human BAK (B5897; Sigma-Aldrich), rabbit anti-
human filamin A (H-300; Santa Cruz Biotechnology),
rabbit anti-human Hic5 (Thermo Fisher Scientific;
PA528839), rabbit anti-human PKCa (Cell Signalling
Technology) (P4334; Sigma-Aldrich), rabbit anti-
human p (T638)PKCa (44962G; Thermo Fisher
Scientific), rabbit anti-human phospho-(Ser) PKC
substrate (Cell Signalling Technology), rabbit anti-
human myosin 1E (HPA023886; Sigma), rabbit anti-
human ARHGAP29 (sc-365554; Santa Cruz Bio-
technology). Alexa Fluor 488 Phalloidin molecular
probe was used to detect actin filaments and tubulin
was detected with a-tubulin rat monoclonal antibody
(YL1/2; Thermo Fisher Scientific). Secondary anti-
bodies conjugated to Alexa Fluor 488 or 594 (Life
Technologies) were used for immunohistochemistry;
secondary antibodies conjugated to Alexa Fluor 680
(Life Technologies) or IRDye 800 (Rockland Immu-
nochemicals) were used for western blotting.
Cell culture
Conditionally immortalized human podocytes [40]
were grown in uncoated tissue culture plates.
Podocytes between passage 10 and 16 were
cultured for 14 days at 37 C in RPMI 1640 medium
with glutamine (R-8758; Sigma-Aldrich) supplemen-
ted with 10% (v/v) foetal calf serum (FCS) (Life
Technologies) and 5% (v/v) ITS (I-1184; Sigma-
Aldrich; 1 ml/100 ml). Glomerular endothelial cells
(GEnCs) were grown in endothelial basal medium-2
(CC-3156; Lonza) containing 5% (v/v) FCS and
EGM-2 BulletKit growth factors (CC-4147; Lonza),
excluding VEGF, for 5 days at 37 C. Retinal pigment
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epithelial (ARPE19) cells were grown in uncoated
tissue culture plates. ARPE19 cells between pas-
sage 16 and 20 were cultured at 37 C in 50%
DMEM4, 50% Ham's F12 medium supplemented
with 10% (v/v) FCS. HEK293T cells were cultured at
37 C in DMEM4 medium supplemented with 10%
(v/v) FCS. Two integrin a3 KO HEK293T cell lines
were generated by CRISPR-Cas9. CRISPR-Cas9
plasmids containing gRNAs against ITGA3 guide 1
(50- TCGGGTATCCAGGTTGAAGG-3) and ITGA3
guide 2 (50-TCCCGGCCTCCTTCACTACC-30) were
acquired from Horizon Discovery (8100 Cambridge
Research Park). Cells were transiently transfected
with constructs containing the gRNA and Cas9
Nickase. Forty-eight hours after transfection, cells
were sorted using fluorescence-activated cell sorting
with an anti-integrin a3 extracellular domain antibody
(IA3 clone; ab20141; Abcam). Integrin a3-negative
cells were collected and single cells were sorted into
individual wells of a 96-well plate. Single-sorted cells
were allowed to expand and deletion of integrin a3
was verified by immunoblotting using a goat anti-
human integrin a3 antibody (I-19; Santa Cruz
Biotechnology).
Isolation of dorsal root ganglia
Dorsal root ganglion neurons (DRGs) were isolated
using a previously described method [41]. Briefly,
following euthanasia, the vertebral column of adult
mice was dissected to collect all of the dorsal root
ganglion neurons (DRGs). DRGs were cleaned to
remove the roots and connective tissue from ganglia,
and incubated with 1.25% collagenase diluted in
Hams F12 for 45 min at 37 C and 5% CO2. The
solution was then removed and replaced with fresh
1.25% collagenase diluted in Hams F12 and incu-
bated for a further 45 min at 37 C and 5% CO2.
Ganglia were washed gently 3 times with Hams F12
and dissociated using a glass pipette. The suspension
was then passed through a sterile 70-mm mesh and
centrifuged at 300 rpm for 5 min. The supernatant was
discarded and the neurones resuspended in 0.5 ml
Hams F12. The resulting cell suspension was then
layered on top of a 15% solution of bovine serum
albumin (fatty acid free, Sigma) diluted in Hams F12.
Finally, the sample was centrifuged at 900 rpm for
10 min. The supernatant was discarded including the
debris layer at the interface, and the cells were
resuspended in media Hams F12 medium containing
NGF, (Sigma cat. no. N6009), 1% N2, (2 mM
progesterone (Sigma cat. no. P8783), 10 mM putres-
cine (Sigma cat. no. P5780), 10 mg/ml transferrin
(Sigma cat no. T8158), 3 mM sodium selenite (Sigma
cat. no. S5261) and 1% AraC.
Flow cytometry
For standard flow cytometric analysis, podocytes
were washed with phosphate-buffered saline without
cations (PBS-) and detached from culture surfaces
with 1 trypsin-EDTA at 37 C. The dissociated cells
were harvested by centrifugation (1000 rpm, 4 min).
The cell pellet was resuspended in 0.1% (w/v) BSA/
0.1% (w/v) sodium azide in PBS- (0.1/0.1 solution).
Cells were then incubated with primary antibody,
diluted in 0.1/0.1 solution, at 4 C for 30 min.
Following two washes with 0.1/0.1 solution and
centrifugation steps, cells were incubated with
appropriate species-specific FITC-conjugated sec-
ondary antibody at 4 C for 30 min. Cells were then
washed three times with 0.1/0.1, resuspended in
PBS- and analysed on a Dako CYAN, FACS
machine.
Matrix ligands
Recombinant human laminin-511 and laminin-521
were a kind gift from Professor Karl Tryggvason, and
can be purchased from BioLamina. Fibronectin from
bovine plasma (F1141) and type IV collagen from
human placenta (C5533) was purchased from
Sigma-Aldrich.
Activators and inhibitors
RGD peptide (Cyclo (-Arg-Gly-Asp-D-Phe-Val)
trifluoroacetate salt) was purchased from BACHEM
(4026200). Drug titration experiment revealed most
impaired cell spreading on fibronectin at 10 mM. In
subsequent spreading assays the RGD peptide was
used at 10 mM. PMA (phorbol 12-myristate 13-
acetate (PMA) was purchased from Sigma-Aldrich
and used at 0.5e50 nM to activate PKC. GӦ6976
was purchased from Sigma-Aldrich and used at
100 nM-10 mM to inhibit PKC.
Attachment assay
For all cell adhesion assays, cells were trypsinized
for 10 min, followed by pipetting cells up and down to
break up cell clumps. Cells were left to trypsinize for
another 5 min, and then pelleted by centrifugation
(1000 rpm for 4 min at room temperature). To
remove cell-bound extracellular matrix, cells were
washed three times with PBS-. Cells were left to
incubate in serum-free RPMI 1640 (podocytes) or
50% DMEM, 50% Ham's-F12 (ARPE19) for 30 min
at 37 C and 5% (v/v) CO2 to downregulate ECM
adhesion signalling events. Subsequently, cells
were pelleted and washed with serum-free RPMI
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1640 (podocytes) or serum-free DMEM5 and spread
on tissue culture dishes coated with ECM ligand
(0e10 mg/ml) or apotransferrin (10 mg/ml). For
quantification percentage of cell attachment, 96-
well plates were blocked with 10 mg/ml heat-
denatured BSA solution followed by coating with
the matrix molecule of interest diluted to the
appropriate concentration in DPBS. Cells were
allowed to attach to matrix-coated wells for
30 min at 37 C. Nonadherent and loosely attached
cells were removed by gently washing the wells with
100 mL of PBS. Cells were fixed in the wells by
addition of 100 mL 5% (w/v) glutaraldehyde for
20 min at room temperature. Subsequently, cells
were stained with 100 mL 0.1% (w/v) crystal violet,
200 mM MES, pH 6.0, for 60 min at room
temperature. Wells were washed three times with
dH2O. Finally, dye was solubilized in 100 mL 10% (v/
v) acetic acid for 5 min at room temperature and
absorbance recorded at 570 nm using a plate
reader. To estimate a value for 100% attachment,
cells were added directly to uncoated plastic in
medium containing serum for 30 min and fixed
without washing. Assays were performed in
quadruplicate.
Micropatterned surfaces
Micropatterned surfaces were created according
to manufacturer's instructions (Primo Alveole). In
brief, glass-bottom dishes (MatTek Corporation)
were coated with a poly (L)-lysine poly ethylene
glycol (PEG) layer (PLL-PEG) (Alveole). Addition of
a photo initiator (PLPP) (Alveole) and UV-light
exposure of the area of interest (circles and lines)
degraded the polymer and made the area of interest
available for coating with collagen IV and laminin.
Circles and lines had an area of 60 mm2. Leonardo
software (Alveole) was used to upload the patterning
designs and an Eclipse Ti inverted microscope
(Nikon) using a 20/0.45 SPlan Fluar objective
was used to expose the dishes to UV-light. Micro-
patterned surfaces were coated with laminin 511 and
collagen IV (both at 5 mg/ml) and podocytes were
spread on the surfaces for 3.5 h in serum-free media.
IAC isolation
IACs were isolated using a similar approach to the
ligand affinity purification method described pre-
viously [32]. For isolation of IACs from podocytes or
ARPE19 cells, cells were treated in the same
manner as for the attachment assay described
above. Cells were spread on tissue culture dishes
coated with ECM ligand (2.5e10 mg/ml) or apo-
transferrin (10 mg/ml) for 180 min following attach-
ment assay described above. Thereafter, cells were
incubated with the membrane-permeable crosslinker
dimethyl-3,3 0-dithiobispropionimidate (DTBP;
Sigma-Aldrich; 6 mM) diluted in Advanced Dulbec-
co's Modified Eagle's Medium (DMEM5) (Sigma-
Aldrich) for 3 min and quenched with Tris-HCl, pH
8.5, after which cells were washed twice with PBS.
Cell bodies were removed by a 1-min incubation with
extraction buffer (10 mM Tris, 150 mM NaCl, 1% (v/
v) Triton X-100, 25 mM EDTA, 25 mg/ml leupeptin,
25 mg/ml aprotinin and 0.5 mM AEBSF). Denuded
cells were subjected to 30 s high-pressure water
wash to removed nuclei. Protein complexes left
bound to the substrate were collected in reducing
sample buffer (50 mM Tris-HCl, pH 6.8, 10% (w/v)
glycerol, 4% (w/v) sodium dodecylsulfate (SDS),
0.004% (w/v) bromophenol blue, 8% (v/v) b-mer-
captoethanol) and incubated at 70 C for 10 min.
Adhesion complex samples were fractionated by
SDS-PAGE and used either for western blotting or
visualized with InstantBlue to be used for in-gel
proteolytic digestion.
MS data acquisition
Following SDSePAGE, gel lanes were sliced and
subjected to in-gel digestion with trypsin [42] with
modifications [8]. Peptide samples were analysed by
liquid chromatography (LC)-tandem MS using a
nanoACQUITY UltraPerformance LC system
(Waters) coupled online to an LTQ Velos mass
spectrometer (Thermo Fisher Scientific) or using an
UltiMate 3000 Rapid Separation LC system (Thermo
Fisher Scientific) coupled online to an Orbitrap Elite
mass spectrometer (Thermo Fisher Scientific). Pep-
tides were concentrated and desalted on a Symme-
try C18 preparative column (20 mm  180 mm, 5-mm
particle size; Waters) and separated on a bridged
ethyl hybrid C18 analytical column (250 mm 75 mm,
1.7-mm particle size; Waters) using a 45-min linear
gradient from 1% to 25% or 8%e33% (v/v) acetoni-
trile in 0.1% (v/v) formic acid at a flow rate of
200 nl min1. Peptides were selected for fragmenta-
tion automatically by data-dependent analysis. The
mass spectrometry proteomics data have been
deposited to the ProteomeXchange Consortium via
the PRIDE [43] partner repository with the dataset
identifier PXD017913.
MS data analysis
Tandem mass spectra were extracted using
extract_msn (Thermo Fisher Scientific) executed in
Mascot Daemon (version 2.4; Matrix Science). Peak
list files were searched against a modified version of
the Uniprot mouse database (version 3.70; release
date, May 3, 2011), containing ten additional
contaminant and reagent sequences of non-mouse
origin, using Mascot (version 2.2.06; Matrix Science)
(Perkins et al., 1999). Carbamidomethylation of
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cysteine was set as a fixed modification; oxidation of
methionine and hydroxylation of proline and lysine
were allowed as variable modifications. Only tryptic
peptides were considered, with up to one missed
cleavage permitted. Monoisotopic precursor mass
values were used, and only doubly and triply
charged precursor ions were considered. Mass
tolerances for precursor and fragment ions were
0.4 Da and 0.5 Da, respectively. MS datasets were
validated using rigorous statistical algorithms at both
the peptide and protein level [44,45] implemented in
Scaffold (version 3.6.5; Proteome Software). Protein
identifications were accepted upon assignment of at
least two unique validated peptides with 90%
probability, resulting in 99% probability at the
protein level. These acceptance criteria resulted in
an estimated protein false discovery rate of 0.1% for
all datasets.
MS data quantification
Relative protein abundance was calculated using
peptide intensity. Orbitrap MS data were entered into
Progenesis LC-MS (Non Linear Dynamics Ltd) and
automatically aligned. Spectra were extracted using
extract_msn executed in Mascot Daemon (version
2.4; Matrix Science) and imported back into Progen-
esis LC-MS to acquire intensity data. Alignment of
chromatograms was carried out using the automatic
alignment algorithm, followed by manual validation
and adjustment of the aligned chromatograms. All
features were used for peptide identifications.
Progenesis LC-MS created the peak list file that
was exported and searched in Mascot. Results were
loaded in Scaffold (Proteome Software Inc, version
3.6.5) and peptide and protein identification thresh-
olds were set to 95% and 99% confidence,
respectively. Data were exported from Scaffold as
a spectrum report, and imported into Progenesis LC-
MS to assign peptide identifications to features.
Peptide and protein data were then exported from
Progenesis LC-MS as.csv files to be analysed in
Excel (Microsoft).
Protein interaction network analysis
Protein interaction network analysis was per-
formed using Cytoscape (version 2.8.1) [46]. Pro-
teins identified in at least two biological replicates
were mapped onto a merged human, mouse and rat
interactome built from Protein Interaction Network
Analysis platform Homo sapiens network (release
date, December 10, 2012), Mus musculus network
(release date, December 10, 2012) and the Rattus
norvegicus network (release date, December 10,
2012) [47], the ECM interactions database MatrixDB
(release date, April 20, 2012) [48], and a literature-
c u r a t e d d a t a b a s e o f i n t e g r i n - b a s e d
adhesioneassociated proteins [49]. For networks
where enrichment is presented, Progenesis LC-MS
normalized intensity data were used. Topological
parameters were computed using the Network
Analyzer plug-in [50].
Immunofluorescence and image analysis
Cells on coverslips were washed with PBS and
then fixed with 4% (w/v) paraformaldehyde. Cells
were permeabilized with 0.5% (v/v) Triton X-100 and
blocked with 3% (w/v) BSA in PBS before incubation
with primary antibodies. Coverslips were mounted
and images were collected using a CoolSnap HQ
camera (Photometrics) and separate DAPI/FITC/
Cy3 filters (U-MWU2, 41001, 41007a, respectively;
Chroma, Olching, Germany) to minimise bleed-
through between the different channels. The images
were collected using a Coolsnap HQ (Photometrics)
camera with a Z optical spacing of 0.2 mm. Images
collected were viewed and analysed with Fiji [51]. To
calculate the area of immunostained marker per cell,
images were edited to remove additional cells and
artefacts outside the required cell area, compiled to
form a hyperstack, background subtracted using a
rolling ball radius of 30, ‘threshold’ function used to
select immunostained marker and to convert images
to black-white binary images, and ‘analyze particles'
function used to calculate total black pixel area.
Some images were acquired on a Delta Vision
(Applied Precision) restoration microscope using a
60 objective and the [Sedat] filter set (Chroma
[89000]).
Ratiometric image analysis
Images were acquired on a Delta Vision Core
(Applied Precision) restoration microscope using a
60/1.42 Plan Apo objective and the Sedat filter set
(Chroma 89000). Images were acquired using a
CSU-X1 spinning disc confocal (Yokagowa) on a
Zeiss Axio-Observer Z1 microscope with a 60 and
100/1.40 Plan-Apochromat objective, Evolve
EMCCD camera (Photometrics) and motorised
XYZ stage (ASI). The 488 nm and 561 nm lasers
were controlled using an AOTF through the laser-
stack (Intelligent Imaging Innovations (3I)) allowing
both rapid ‘shuttering’ of the laser and attenuation of
the laser power. To analyze focal adhesions, back-
ground was subtracted using the rolling ball function.
Cells were co-immunostained with paxillin (Mus) and
phospho paxillin Y118 (Rabbit) or PKCa (Rabbit)
antibodies and images were acquired using the
same exposure time between channels. Focal
adhesions (20e25 per cell) were manually selected
for analysis by drawing regions of interest (ROIs).
ROIs were used to measure the integrated density of
the FAs in both channels. A ratio of the integrated
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density between both channels was calculated as
described before [52].
Immunoblotting
Following SDS-PAGE, resolved proteins were
transferred to nitrocellulose membrane (Whatman).
Membranes were washed and incubated with anti-
bodies as described previously [8]. Briefly, mem-
branes were blocked with casein blocking buffer
(Sigma-Aldrich) and probed with primary antibodies
diluted in blocking buffer containing 0.05% (v/v)
Tween 20. Membranes were washed with Tris-
buffered saline plus Tween 20 and incubated with
species-specific fluorescent dyeeconjugated sec-
ondary antibodies diluted in blocking buffer contain-
ing 0.05% (v/v) Tween 20. Membranes were washed
in the dark and then scanned using the Odyssey
infrared imaging system (LI-COR Biosciences) to
visualize bound antibodies.
GST-PAK pull-down
Active Rac1 was purified from lysates using a pull-
down approach with GST-PAK beads. Cells were
prepared as described for attachment assays prior to
plating on 5 mg/ml matrix-coated dishes. At various
times, 0, 15, 30 and 210 min of cell spreading, cells
were lysed in ice-cold lysis buffer [20 mM Hepes, pH
7.5, 1% (wt/vol) Igepal, 0.5% (wt/vol) sodium
deoxycholate, 140 mM NaCl, 4 mM EDTA, 4 mM
EGTA, 10% (wt/vol) glycerol), and lysates were
clarified by centrifugation at 12,000 g, 4 C, for 1 min.
Lysates were then incubated with GST-PAK beads
for 1 h at 4 C. Beads were washed three times with
ice-cold lysis buffer as described above, and active
GTPase was eluted off beads by addition of reducing
sample buffer. Samples were then resolved by SDS-
PAGE and analysed by western blotting.
Statistical analysis
Data presented as bar graphs or box-and-whisker
plots were analysed by Shapiro-Wilk test for normal-
ity and analysed by Kruskal-Wallis test or ANOVA
with post-hoc Bonferroni correction as appropriate.
Principal component analysis was performed in
MATLAB. Unsupervised hierarchical clustering was
performed in T4MeV using a Euclidean distance-
based complete-linkage matrix.
Conflicts of interest
The authors declare no conflicts of interests.
Acknowledgements
This work was supported by a Wellcome Trust
Senior Fellowship award (202860/Z/16/Z) to R.L., a
Kidney Research UK grant (RP52/2014) awarded to
R.L and J.H.M to support a PDRA position for M.J.R
and Cancer Research UK (C13329) and Wellcome
Trust (092015) grants to M.J.H. R.Z. is supported by
Veterans Affairs Merit Awards 1I01BX002196-01
and DK069221. J.H.M. is supported by NIH grants
R01DK058366 and R01DK078314. We acknowl-
edge Dr Hellyeh Hamidi for the initial optimization
experiments for this work, Dr Emma Hilton for advice
about extraction of dorsal root ganglia and Dr
Christoph Ballestrem for advice about patterned
surfaces. The mass spectrometer and microscopes
used in this study were purchased with grants from
the Biotechnology and Biological Sciences
Research Council, Wellcome Trust and the Univer-
sity of Manchester Strategic Fund. Mass spectro-
metry was performed in the Biomolecular Analysis
Core Facility, Faculty of Life Sciences, University of
Manchester, and we thank David Knight and Stacey
Warwood for advice and technical support and
Julian Selley for bioinformatic support.
Appendix A. Supplementary data
Supplementary data to this article can be found
online at https://doi.org/10.1016/j.matbio.2020.02.
005.
Received 15 September 2019;
Received in revised form 29 February 2020;
Accepted 29 February 2020









1These authors contributed equally to this work.
76 Basement membrane ligands distinct
#Present address: Faculty of Medicine, Dentistry
and Life Sciences, Chester Medical School, Uni-
versity of Chester, Chester, UK.
References
[1] J.H. Miner, B.L. Patton, S.I. Lentz, D.J. Gilbert, W.D. Snider,
N.A. Jenkins, N.G. Copeland, J.R. Sanes, The laminin alpha
chains: expression, developmental transitions, and chromo-
somal locations of alpha1-5, identification of heterotrimeric
laminins 8-11, and cloning of a novel alpha3 isoform, J. Cell
Biol. 137 (1997) 685e701.
[2] J.H. Miner, J.R. Sanes, Collagen IV alpha 3, alpha 4, and
alpha 5 chains in rodent basal laminae: sequence, distribu-
tion, association with laminins, and developmental switches,
J. Cell Biol. 127 (1994) 879e891.
[3] S.E. Winograd-Katz, R. Fassler, B. Geiger, K.R. Legate,
The integrin adhesome: from genes and proteins to
human disease, Nat. Rev. Mol. Cell Biol. 15 (2014)
273e288.
[4] R. Zaidel-Bar, S. Itzkovitz, A. Ma'ayan, R. Iyengar, B. Geiger,
Functional atlas of the integrin adhesome, Nat. Cell Biol. 9
(2007) 858e867.
[5] H.B. Schiller, C.C. Friedel, C. Boulegue, R. Fassler, Quanti-
tative proteomics of the integrin adhesome show a myosin II-
dependent recruitment of LIM domain proteins, EMBO Rep.
12 (2011) 259e266.
[6] H.B. Schiller, M.R. Hermann, J. Polleux, T. Vignaud,
S. Zanivan, C.C. Friedel, Z. Sun, A. Raducanu,
K.E. Gottschalk, M. Thery, M. Mann, R. Fassler, beta1-
and alphav-class integrins cooperate to regulate myosin II
during rigidity sensing of fibronectin-based microenviron-
ments, Nat. Cell Biol. 15 (2013) 625e636.
[7] J.C. Kuo, X. Han, C.T. Hsiao, J.R. Yates 3rd,
C.M. Waterman, Analysis of the myosin-II-responsive focal
adhesion proteome reveals a role for beta-Pix in negative
regulation of focal adhesion maturation, Nat. Cell Biol. 13
(2011) 383e393.
[8] J.D. Humphries, A. Byron, M.D. Bass, S.E. Craig,
J.W. Pinney, D. Knight, M.J. Humphries, Proteomic analysis
of integrin-associated complexes identifies RCC2 as a dual
regulator of Rac1 and Arf6, Sci. Signal. 2 (2009) ra51.
[9] A. Byron, J.A. Askari, J.D. Humphries, G. Jacquemet,
E.J. Koper, S. Warwood, C.K. Choi, M.J. Stroud,
C.S. Chen, D. Knight, M.J. Humphries, A proteomic ap-
proach reveals integrin activation state-dependent control of
microtubule cortical targeting, Nat. Commun. 6 (2015) 6135.
[10] J. Robertson, G. Jacquemet, A. Byron, M.C. Jones,
S. Warwood, J.N. Selley, D. Knight, J.D. Humphries,
M.J. Humphries, Defining the phospho-adhesome through
the phosphoproteomic analysis of integrin signalling, Nat.
Commun. 6 (2015) 6265.
[11] A. Byron, J.D. Humphries, S.E. Craig, D. Knight,
M.J. Humphries, Proteomic analysis of alpha4beta1 integrin
adhesion complexes reveals alpha-subunit-dependent pro-
tein recruitment, Proteomics 12 (2012) 2107e2114.
[12] E.R. Horton, A. Byron, J.A. Askari, D.H. Ng, A. Millon-
Fremillon, J. Robertson, E.J. Koper, N.R. Paul, S. Warwood,
D. Knight, J.D. Humphries, M.J. Humphries, Definition of a
consensus integrin adhesome and its dynamics during
adhesion complex assembly and disassembly, Nat. Cell
Biol. 17 (2015) 1577e1587.
[13] J.D. Humphries, A. Byron, M.J. Humphries, Integrin ligands
at a glance, J. Cell Sci. 119 (2006) 3901e3903.
[14] R. Lennon, M.J. Randles, M.J. Humphries, The importance
of podocyte adhesion for a healthy glomerulus, Front.
Endocrinol. 5 (2014) 160.
[15] N. Sachs, A. Sonnenberg, Cell-matrix adhesion of podo-
cytes in physiology and disease, Nat. Rev. Nephrol. 9 (2013)
200e210.
[16] V. Matejas, B. Hinkes, F. Alkandari, L. Al-Gazali,
E. Annexstad, M.B. Aytac, M. Barrow, K. Blahova,
D. Bockenhauer, H.I. Cheong, I. Maruniak-Chudek,
P. Cochat, J. Dotsch, P. Gajjar, R.C. Hennekam,
F. Janssen, M. Kagan, A. Kariminejad, M.J. Kemper,
J. Koenig, J. Kogan, H.Y. Kroes, E. Kuwertz-Broking,
A.F. Lewanda, A. Medeira, J. Muscheites, P. Niaudet,
M. Pierson, A. Saggar, L. Seaver, M. Suri, A. Tsygin,
E. Wuhl, A. Zurowska, S. Uebe, F. Hildebrandt, C. Antignac,
M. Zenker, Mutations in the human laminin beta2 (LAMB2)
gene and the associated phenotypic spectrum, Hum. Mutat.
31 (2010) 992e1002.
[17] B.G. Hudson, K. Tryggvason, M. Sundaramoorthy,
E.G. Neilson, Alport's syndrome, Goodpasture's syndrome,
and type IV collagen, N. Engl. J. Med. 348 (2003)
2543e2556.
[18] S.D. Funk, M.H. Lin, J.H. Miner, Alport syndrome and
Pierson syndrome: diseases of the glomerular basement
membrane, Matrix Biol. 71e72 (2018) 250e261.
[19] R.V. Iozzo, M.A. Gubbiotti, Extracellular matrix: the driving
force of mammalian diseases, Matrix Biol. 71e72 (2018)
1e9.
[20] H. Suleiman, L. Zhang, R. Roth, J.E. Heuser, J.H. Miner,
A.S. Shaw, A. Dani, Nanoscale protein architecture of the
kidney glomerular basement membrane, eLife 2 (2013),
e01149.
[21] R. Nishiuchi, J. Takagi, M. Hayashi, H. Ido, Y. Yagi,
N. Sanzen, T. Tsuji, M. Yamada, K. Sekiguchi, Ligand-
binding specificities of laminin-binding integrins: a compre-
hensive survey of laminin-integrin interactions using recom-
binant alpha3beta1, alpha6beta1, alpha7beta1 and
alpha6beta4 integrins, Matrix Biol. : J. Int. Soc. Matrix Biol.
25 (2006) 189e197.
[22] H. Colognato-Pyke, J.J. O'Rear, Y. Yamada, S. Carbonetto,
Y.S. Cheng, P.D. Yurchenco, Mapping of network-forming,
heparin-binding, and alpha 1 beta 1 integrin-recognition sites
within the alpha-chain short arm of laminin-1, J. Biol. Chem.
270 (1995) 9398e9406.
[23] H. Colognato, M. MacCarrick, J.J. O'Rear, P.D. Yurchenco,
The laminin alpha2-chain short arm mediates cell adhesion
through both the alpha1beta1 and alpha2beta1 integrins,
J. Biol. Chem. 272 (1997) 29330e29336.
[24] P.K. Nielsen, Y. Yamada, Identification of cell-binding sites
on the Laminin alpha 5 N-terminal domain by site-directed
mutagenesis, J. Biol. Chem. 276 (2001) 10906e10912.
[25] J.H. Garbe, W. Gohring, K. Mann, R. Timpl, T. Sasaki,
Complete sequence, recombinant analysis and binding to
laminins and sulphated ligands of the N-terminal domains of
laminin alpha3B and alpha5 chains, Biochem. J. 362 (2002)
213e221.
[26] M. Balasubramani, E.M. Schreiber, J. Candiello,
G.K. Balasubramani, J. Kurtz, W. Halfter, Molecular inter-
actions in the retinal basement membrane system: a
proteomic approach, Matrix Biol. 29 (2010) 471e483.
[27] G. Uechi, Z. Sun, E.M. Schreiber, W. Halfter,
M. Balasubramani, Proteomic view of basement mem-
77Basement membrane ligands distinct
branes from human retinal blood vessels, inner limiting
membranes, and lens capsules, J. Proteome Res. 13 (8)
(2014 Aug 1) 3693e3705.
[28] R. Lennon, A. Byron, J.D. Humphries, M.J. Randles,
A. Carisey, S. Murphy, D. Knight, P.E. Brenchley, R. Zent,
M.J. Humphries, Global analysis reveals the complexity of
the human glomerular extracellular matrix, J. Am. Soc.
Nephrol. 25 (2014) 939e951.
[29] P. Mundel, H.W. Heid, T.M. Mundel, M. Kruger, J. Reiser,
W. Kriz, Synaptopodin: an actin-associated protein in
telencephalic dendrites and renal podocytes, J. Cell Biol.
139 (1997) 193e204.
[30] K. Shen, C.I. Bargmann, The immunoglobulin superfamily
protein SYG-1 determines the location of specific synapses
in C. elegans, Cell 112 (2003) 619e630.
[31] A.R. Evans, S. Euteneuer, E. Chavez, L.M. Mullen, E.E. Hui,
S.N. Bhatia, A.F. Ryan, Laminin and fibronectin modulate
inner ear spiral ganglion neurite outgrowth in an in vitro
alternate choice assay, Dev. Neurobiol. 67 (2007)
1721e1730.
[32] M.C. Jones, J.D. Humphries, A. Byron, A. Millon-Fremillon,
J. Robertson, N.R. Paul, D.H. Ng, J.A. Askari,
M.J. Humphries, Isolation of integrin-based adhesion
complexes, Curr. Protoc. Cell. Biol 66 (9 8 1e9 8 15)
(2015).
[33] G. Jacquemet, M.R. Morgan, A. Byron, J.D. Humphries,
C.K. Choi, C.S. Chen, P.T. Caswell, M.J. Humphries, Rac1
is deactivated at integrin activation sites through an
IQGAP1-filamin-A-RacGAP1 pathway, J. Cell Sci. 126
(2013) 4121e4135.
[34] C. Mele, P. Iatropoulos, R. Donadelli, A. Calabria,
R. Maranta, P. Cassis, S. Buelli, S. Tomasoni, R. Piras,
M. Krendel, S. Bettoni, M. Morigi, M. Delledonne,
C. Pecoraro, I. Abbate, M.R. Capobianchi, F. Hildebrandt,
E. Otto, F. Schaefer, F. Macciardi, F. Ozaltin, S. Emre,
T. Ibsirlioglu, A. Benigni, G. Remuzzi, M. Noris, C. PodoNet,
MYO1E mutations and childhood familial focal segmental
glomerulosclerosis, N. Engl. J. Med. 365 (2011) 295e306.
[35] R. Lennon, H.M. Stuart, A. Bierzynska, M.J. Randles,
B. Kerr, K.A. Hillman, G. Batra, J. Campbell, H. Storey,
F.A. Flinter, A. Koziell, G.I. Welsh, M.A. Saleem, N.J. Webb,
A.S. Woolf, Coinheritance of COL4A5 and MYO1E muta-
tions accentuate the severity of kidney disease, Pediatr.
Nephrol. 30 (2015) 1459e1465.
[36] S. Schlie-Wolter, A. Ngezahayo, B.N. Chichkov, The
selective role of ECM components on cell adhesion,
morphology, proliferation and communication in vitro, Exp.
Cell Res. 319 (2013) 1553e1561.
[37] M.J. Randles, M.J. Humphries, R. Lennon, Proteomic
definitions of basement membrane composition in health
and disease, Matrix Biol. 57e58 (2017) 12e28.
[38] D.P. Keeley, D.R. Sherwood, Tissue linkage through
adjoining basement membranes: the long and the short
term of it, Matrix Biol. 75e76 (2019) 58e71.
[39] W.L. Lei, S.G. Xing, C.Y. Deng, X.C. Ju, X.Y. Jiang,
Z.G. Luo, Laminin/beta1 integrin signal triggers axon
formation by promoting microtubule assembly and stabiliza-
tion, Cell Res. 22 (2012) 954e972.
[40] M.A. Saleem, M.J. O'Hare, J. Reiser, R.J. Coward,
C.D. Inward, T. Farren, C.Y. Xing, L. Ni, P.W. Mathieson,
P. Mundel, A conditionally immortalized human podocyte
cell line demonstrating nephrin and podocin expression,
J. Am. Soc. Nephrol. 13 (2002) 630e638.
[41] R.M. Lindsay, Nerve growth factors (NGF, BDNF) enhance
axonal regeneration but are not required for survival of adult
sensory neurons, J. Neurosci. 8 (1988) 2394e2405.
[42] A. Shevchenko, M. Wilm, O. Vorm, M. Mann, Mass
spectrometric sequencing of proteins silver-stained poly-
acrylamide gels, Anal. Chem. 68 (1996) 850e858.
[43] J.A. Vizcaino, A. Csordas, N. Del-Toro, J.A. Dianes, J. Griss,
I. Lavidas, G. Mayer, Y. Perez-Riverol, F. Reisinger,
T. Ternent, Q.W. Xu, R. Wang, H. Hermjakob, Update of
the PRIDE database and its related tools, Nucleic Acids
Res. 44 (2016) 11033, 2016.
[44] A.I. Nesvizhskii, A. Keller, E. Kolker, R. Aebersold,
A statistical model for identifying proteins by tandem mass
spectrometry, Anal. Chem. 75 (2003) 4646e4658.
[45] A. Keller, A.I. Nesvizhskii, E. Kolker, R. Aebersold, Empirical
statistical model to estimate the accuracy of peptide
identifications made by MS/MS and database search, Anal.
Chem. 74 (2002) 5383e5392.
[46] P. Shannon, A. Markiel, O. Ozier, N.S. Baliga, J.T. Wang,
D. Ramage, N. Amin, B. Schwikowski, T. Ideker, Cytoscape:
a software environment for integrated models of biomole-
cular interaction networks, Genome Res. 13 (2003)
2498e2504.
[47] J. Wu, T. Vallenius, K. Ovaska, J. Westermarck,
T.P. Makela, S. Hautaniemi, Integrated network analysis
platform for protein-protein interactions, Nat. Methods 6
(2009) 75e77.
[48] E. Chautard, L. Ballut, N. Thierry-Mieg, S. Ricard-Blum,
MatrixDB, a database focused on extracellular protein-
protein and protein-carbohydrate interactions, Bioinformatics
25 (2009) 690e691.
[49] R. Zaidel-Bar, B. Geiger, The switchable integrin adhesome,
J. Cell Sci. 123 (2010) 1385e1388.
[50] Y. Assenov, F. Ramirez, S.E. Schelhorn, T. Lengauer,
M. Albrecht, Computing topological parameters of biological
networks, Bioinformatics 24 (2008) 282e284.
[51] J. Schindelin, I. Arganda-Carreras, E. Frise, V. Kaynig,
M. Longair, T. Pietzsch, S. Preibisch, C. Rueden,
S. Saalfeld, B. Schmid, J.Y. Tinevez, D.J. White,
V. Hartenstein, K. Eliceiri, P. Tomancak, A. Cardona, Fiji:
an open-source platform for biological-image analysis, Nat.
Methods 9 (2012) 676e682.
[52] R. Zaidel-Bar, C. Ballestrem, Z. Kam, B. Geiger, Early
molecular events in the assembly of matrix adhesions at the
leading edge of migrating cells, J. Cell Sci. 116 (2003)
4605e4613.
78 Basement membrane ligands distinct
